Have a personal or library account? Click to login
Inhibition of blood group antibodies by soluble substances Cover

Inhibition of blood group antibodies by soluble substances

Immunohematology
Volume 35 (2019): Issue 1 (March 2019)
By: K.M. Byrne,  C.M.C. Mercado,  T.N. Nnabue,  T.D. Paige and  W.A. Flegel  
Paid access
|Feb 2020

Authors

K.M. Byrne

KByrne@cc.nih.gov

National Institutes of Health (NIH) Clinical Center, Department of Transfusion Medicine, Bethesda, US

C.M.C. Mercado

American Red Cross, Pomona, US

T.N. Nnabue

Transfusion Medicine, Walter Reed National Military Medical Center, Bethesda, US

T.D. Paige

National Institutes of Health (NIH) Clinical Center, Department of Transfusion Medicine, Bethesda, US

W.A. Flegel

National Institutes of Health (NIH) Clinical Center, Department of Transfusion Medicine, Bethesda, US
DOI: https://doi.org/10.21307/immunohematology-2020-008 | Journal eISSN: 1930-3955 | Journal ISSN: 0894-203X
Journal RSS Feed
Language: English
Page range: 19 - 22
Published on: Feb 15, 2020
Published by: American National Red Cross
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
soluble blood group substance,
dilution control,
neutralization,
soluble peptide,
inhibition,
recombinant blood group proteins
Related subjects:
Medicine,
Clinical medicine,
Laboratory medicine

© 2020 K.M. Byrne, C.M.C. Mercado, T.N. Nnabue, T.D. Paige, W.A. Flegel, published by American National Red Cross
This work is licensed under the Creative Commons License.

Previous articleVolume 35 (2019): Issue 1 (March 2019)Next article